1. Home
  2. A vs LEN Comparison

A vs LEN Comparison

Compare A & LEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • A
  • LEN
  • Stock Information
  • Founded
  • A 1999
  • LEN 1954
  • Country
  • A United States
  • LEN United States
  • Employees
  • A N/A
  • LEN N/A
  • Industry
  • A Biotechnology: Laboratory Analytical Instruments
  • LEN Homebuilding
  • Sector
  • A Industrials
  • LEN Consumer Discretionary
  • Exchange
  • A Nasdaq
  • LEN Nasdaq
  • Market Cap
  • A 38.6B
  • LEN N/A
  • IPO Year
  • A 1999
  • LEN N/A
  • Fundamental
  • Price
  • A $116.70
  • LEN $118.22
  • Analyst Decision
  • A Buy
  • LEN Buy
  • Analyst Count
  • A 13
  • LEN 16
  • Target Price
  • A $151.50
  • LEN $143.93
  • AVG Volume (30 Days)
  • A 2.1M
  • LEN 3.3M
  • Earning Date
  • A 02-26-2025
  • LEN 03-20-2025
  • Dividend Yield
  • A 0.85%
  • LEN 1.75%
  • EPS Growth
  • A 4.31
  • LEN 4.22
  • EPS
  • A 4.36
  • LEN 14.31
  • Revenue
  • A $6,533,000,000.00
  • LEN $35,441,452,000.00
  • Revenue This Year
  • A $5.84
  • LEN $6.03
  • Revenue Next Year
  • A $6.23
  • LEN $5.85
  • P/E Ratio
  • A $26.77
  • LEN $7.96
  • Revenue Growth
  • A N/A
  • LEN 3.53
  • 52 Week Low
  • A $116.36
  • LEN $111.26
  • 52 Week High
  • A $155.35
  • LEN $187.61
  • Technical
  • Relative Strength Index (RSI)
  • A 29.80
  • LEN 43.04
  • Support Level
  • A $117.92
  • LEN $111.26
  • Resistance Level
  • A $124.43
  • LEN $122.82
  • Average True Range (ATR)
  • A 2.97
  • LEN 3.60
  • MACD
  • A 0.26
  • LEN 0.05
  • Stochastic Oscillator
  • A 4.15
  • LEN 35.87

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: